Abstract: Diabetes/Metabolism ReviewsVolume 11, Issue 4 p. 337-363 Article Pancreas transplantation: An update David E. R. Sutherland, Corresponding Author David E. R. Sutherland University of Minnesota Hospital and Clinic, Minneapolis, USAUniversity of Minnesota Hospital and Clinic, Box 280, 420 Delaware Street S.E., Minneapolis, MN 55455, USASearch for more papers by this authorRainer W.G. Gruessner, Rainer W.G. Gruessner University of Minnesota Hospital and Clinic, Minneapolis, USASearch for more papers by this authorPaul F. Gores, Paul F. Gores University of Minnesota Hospital and Clinic, Minneapolis, USASearch for more papers by this authorKenneth Brayman, Kenneth Brayman University of Minnesota Hospital and Clinic, Minneapolis, USASearch for more papers by this authorDavid Wahoff, David Wahoff University of Minnesota Hospital and Clinic, Minneapolis, USASearch for more papers by this authorAngelika Gruessner, Angelika Gruessner University of Minnesota Hospital and Clinic, Minneapolis, USASearch for more papers by this author David E. R. Sutherland, Corresponding Author David E. R. Sutherland University of Minnesota Hospital and Clinic, Minneapolis, USAUniversity of Minnesota Hospital and Clinic, Box 280, 420 Delaware Street S.E., Minneapolis, MN 55455, USASearch for more papers by this authorRainer W.G. Gruessner, Rainer W.G. Gruessner University of Minnesota Hospital and Clinic, Minneapolis, USASearch for more papers by this authorPaul F. Gores, Paul F. Gores University of Minnesota Hospital and Clinic, Minneapolis, USASearch for more papers by this authorKenneth Brayman, Kenneth Brayman University of Minnesota Hospital and Clinic, Minneapolis, USASearch for more papers by this authorDavid Wahoff, David Wahoff University of Minnesota Hospital and Clinic, Minneapolis, USASearch for more papers by this authorAngelika Gruessner, Angelika Gruessner University of Minnesota Hospital and Clinic, Minneapolis, USASearch for more papers by this author First published: December 1995 https://doi.org/10.1002/dmr.5610110404Citations: 21AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Kelly WD, Lillehei RC, Merkel FK, Idezuki T, and Goetz FC: Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 61: 827– 820, 1967. 2 Sutherland DER, Gores PF, Farney AC, Wahoff DC, Matas AJ, Dunn DL, Gruessner RWG, and Najarian JS: Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota. Am J Surg 166: 456– 491, 1993. 3 Lillehei RC, Simmons RL, and Najarian JS: Pancreatico-duodenal allotransplantation: experimental and clinical experience. Diabetes Care 172: 405– 436, 1970. 4 Gliedman ML, Tellis VA, and Soberman R: Long-term effects of pancreatic transplant function in patients with advanced juvenile onset diabetes. Diabetes Care 1: 1– 9, 1978. 5 Dubernard JM, Treaeger J, Neyra P, Touraine JL, Traudiant D, and Blanc-Brunat N: A new method of preparation of segmental pancreatic grafts for transplantation: trials in dogs and in man. Surgery 84: 633– 640, 1978. 6 Groth CG, Lundgren G, Arner P, Cellste H, Hardstedt C, Lewander R, and Ostman J: Rejection of isolated pancreatic allografts in patients with diabetes. Surg Gynecol Obstet 143: 933– 940, 1976. 7 Sutherland DER: International human pancreas and islet transplant registry. Transplant Proc 12: 229– 236, 1980. 8 Sutherland DER, Moudry-Munns KC, and Gillingham KJ: Report from the International Pancreas Transplant Registry. Diabetologia 34: S28– S39, 1991. 9 International Pancreas Transplant Registry: Newsletter 8 (No.1): Supplemental, Annual Report of IPTR, 15 June 1995. 10 Gruessner AC, and Sutherland DER: Pancreas Transplant Registry, United Network for Organ Sharing and International Data Report. In Clinical Transplantation–1994, PI Terasaki, Ed. UCLA Tissue Typing Labs, Los Angeles, 1995, pp. 46– 68. 11 Morel P, Goetz FC, Moudry-Munns KC, Freier EF, and Sutherland DER: Long term glucose control in patients with pancreatic transplants. Ann Intern Med 115: 694– 699, 1991. 12 Gruessner RWG, Manivel DC, Dunn DL, and Sutherland DER: Pancreaticoduodenal transplantation with enteric drainage following native total pancreatectomy for chronic pancreatitis: a case report. Pancreas 6: 479– 488, 1991. 13 Hering BJ, Browatzki CC, Schultz A, Bretzel RG, and Federlin KF: Clinical islet transplantation: registry report, accomplishments in the past and future research needs. Cell Transplant 2: 269– 282, 1993. 14 Federlin KF, Bretzel RG, and Hering BJ: International islet transplant registry. Newsletter 5: 1– 20, 1994. 15 Sutherland DER, Moudry-Munns KC, and Gruessner, AC: Pancreas Transplant Registry, United Network for Organ Sharing and International Data Report. In Clinical Transplants 1993, PI Terasaki, Ed. UCLA Tissue Typing Laboratory, Los Angeles, 1994, pp 47– 69. 16 Lacy PE: Status of islet cell transplantation. Diabetes Care 1: 76– 92, 1993. 17 Morel P, Goetz FC, Moudry-Munns KC, Freier EF, and Sutherland DER: Serial glycosylated hemoglobin levels in diabetic recipients of pancreatic transplants. Transplant Proc 22: 649– 650, 1990. 18 Sutherland DER: Immunosuppression for clinical pancreas transplantation. Clin Transplant 5: 549– 553, 1991. 19 Sutherland DER: Present status of pancreas transplantation alone in nonuremic diabetic patients. Transplant Proc 26: 379– 383, 1994. 20 Sollinger HW: Current status of simultaneous pancreas-kidney transplantation. Transplant Proc 26: 375– 378, 1994. 21 Eisenbarth GS: Type I diabetes mellitus: a chronic autoimmune disease. N Engl J Med 314: 1360– 1368, 1986. 22 Bottazzo GF: Banting Lecture. On the honey disease: a dialogue with Socrates. Diabetes 42: 778– 800, 1993. 23 Atkinson MA, and Maclaren NK: The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331: 1428– 1436, 1994. 24 Sutherland DER, and Sibley RK: Recurrence of Disease in Pancreas Transplants. Elsevier, Amsterdam, pp. 60– 66, 1988. 25 Sutherland DER, Sibley RK, Xu XZ, Michael AF, Srikanta S, Taub F, Najarian JS, and Goetz FC: Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type I diabetes. Trans Assoc Amer Physicians 97: 80– 87, 1984. 26 Sibley RK, Sutherland DER, Goetz FC, and Michael AF: Recurrent diabetes mellitus in the pancreas iso- and allograft: a light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 53: 132– 144, 1985. 27 Sutherland DER, Goetz FC, and Sibley RK: Recurrence of disease in pancreas transplants. Diabetes 38: 85– 87, 1989. 28 Hanssen KF, Dahl-Jorgenson K, and Lauritzen J: Diabetic control and microvascular complications: the near normoglycemic experience. Diabetologia 10: 677– 684, 1986. 29 DCCT Research Group: Diabetes control and complications trial (DCCT): The effect of intensive diabetes treatment in long term complications in IDDM. N Engl J Med 329: 977– 986, 1993. 30 Jacobson SH, Fryd DS, Sutherland DER, and Kjellstrand CM: Treatment of the diabetic patient with end-stage renal failure. Diabetes Metab Rev 4: 191– 200, 1988. 31 Cheung AHS, Sutherland DER, Gillingham KJ, McHugh LE, Moudry-Munns KC, Dunn DL, Najarian JS, and Matas AJ: Simultaneous pancreas-kidney (SPK) transplant versus kidney transplant alone (KTA) in diabetic patients. Kidney Int 41: 924– 929, 1992. 32 Gruessner AC, Gruessner RWG, Moudry-Munns KC, Dunn DL, Najarian JS, and Sutherland DER: Influence of multiple factors (age, transplant number, recipient category, donor source) on outcome of pancreas transplantation at one institution. Transplant Proc 25: 1303– 1305, 1993. 33 Gross CR, and Zehrer CL: Impact of the addition of a pancreas to quality of life in uremic diabetic recipients of kidney transplants. Transplant Proc 25: 1293– 1295, 1993. 34 Sutherland DER: Effect of pancreas transplants on secondary complications of diabetes: review of observations of a single institution. Transplant Proc 24: 859– 860, 1992. 35 Morris RP: Rapamycins: antifungal, antitumor, antiproliferative, and immunosuppressive macrolides. Transplant Rev 6 (No.1): 39– 87, 1992. 36 Sutherland DER: Pancreatic transplantation: state of the art. Transplant Proc 24: 762– 766, 1992. 37 Perkins JD, Frohner PP, Service FJ, Wilhelm MP, Keating MR, DiCecco SR, Johnson JL, Munn SR, and Velosa JA: Pancreas transplantation at Mayo. III. Multidisciplinary. Mayo Clin Proc. 65: 496– 508, 1990. 38 Sutherland DER, Dunn DL, Goetz FC, Kennedy WR, Ramsay RC, Steffes MW, Mauer SM, Gruessner RWG, Moudry-Munns KC, Morel P, Viste AB, Robertson RP, and Najarian JS: A 10-year experience with 290 pancreas transplants at a single institution. Ann Surg 210: 274– 285, 1989. 39 Stratta RJ, Taylor RJ, Ozaki CF, Bynon JS, Miller SA, Knight TF, Fischer JL, Neumann TV, Wahl TO, Duckworth WC, Langnas AN, and Shaw BBW: A comparative analysis of results and morbidity in type I diabetics under-going preemptive versus post-dialysis combined pancreas-kidney transplantation. Transplantation 55 (5): 1097– 1103, 1993. 40 Gruessner RWG, Dunn DL, Gruessner AC, Matas AJ, Najarian JS, and Sutherland DER: Recipient risk factors have an impact on technical failure and patient and graft survival rates in bladder-drained pancreas transplants. Transplantation 57: 1598– 1606, 1994. 41 Bolinder J, Wahrenberg H, Linde B, Tydén G, Groth CG, and Ostman S: Improved glucose counterregulation after pancreas transplantation in diabetic patients with unawareness of hypoglycemia. Transplant Proc 23: 1667– 1669, 1991. 42 Diem P, Redmon JB, Abid M, Moran A, Sutherland DER, Halter JB, and Robertson RP: Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts. J Clin Invest 86: 2008– 2013, 1990. 43 Barrou Z, Seaquist ER, and Robertson RP: Pancreas transplantation in diabetic human normalizes hepatic glucose production during hypoglycemia. Diabetes 43: 661– 666, 1994. 44 Zehrer CL, and Gross CR: Quality of life of pancreas transplant recipients. Diabetologia 34: S145– S140, 1991. 45 Dubernard JM, Martin X, Sanseverino R, and Gelet, A: Surgical techniques and complications. In International Handbook of Pancreas Transplantation, JM Dubernard, and DER Sutherland, Eds. Kluwer, Dordrecht, 1988, pp. 71– 130. 46 Brayman KL, Najarian JS, and Sutherland DER. Current Surgical Therapy. Decker, Toronto, 1994, pp. 458– 475. 47 Calne RY: Paratopic segmental pancreas grafting: a technique with portal venous drainage. Lancet i: 595, 1984. 48 Gilbert-Vernet JM, Fernandez-Cruz L, Andreu J, Figuerola D, and Caralps A: A clinical experience with pancreaticopyelostomy for exocrine pancreatic drainage and portal venous drainage in pancreas transplantation. Transplant Proc 17: 342, 1985. 49 Tydén G, Wilczek H, and Lundgren G: Experience with 21 intraperitoneal segmental pancreatic transplants with enteric or gastric exocrine diversion in humans. Transplant Proc 17: 331, 1985. 50 Sutherland DER, Goetz FC, Moudry KC, Abouna GM, and Najarian JS: Use of recipient mesenteric vessels for revascularization of segmental pancreas grafts: technical and metabolic considerations. Transplant Proc 19: 2300– 2304, 1987. 51 Müehlbacher F, Gnant MF, and Auinger M: Pancreatic venous drainage to the portal vein: a new method in human pancreas transplantation. Transplant Proc 22: 636, 1990. 52 Rosenlof LK, Earnhardt RC, Pruett TL, Stevenson WC, Douglas MT, Cornett GC, and Hanks JB: Pancreas transplantation: an initial experience with systemic and portal drainage of pancreatic allografts. Ann Surg 215: 586– 595, 1992. 53 Gaber AO, Shokouh-Amiri MH, Grewal HP, and Britt LG: A technique for portal pancreas transplantation with enteric drainage. Surg Gynecol Obstet 177 (4): 417– 419, 1993. 54 Diem P, Manuir A, and Redmon JB: Systemic drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes 39: 534– 540, 1990. 55 Sutherland DER, Goetz FC, Gillingham KJ, Moudry-Munns KC, and Najarian JS: Medical risks and benefit of pancreas transplants from living related donors. In W Land, JB Dossetor eds. Organ Replacement Therapy: Ethics, Justice and Commerce. Berlin, Heidelberg: Springer-Verlag, 93– 101, 1991. 56 Cheung AHS, Matas AJ, Gruessner RWG, Dunn DL, Moudry-Munns KC, Najarian JS, and Sutherland DER: Should uremic diabetic patients who want a pancreas transplant receive a simultaneous cadaver kidney-pancreas transplant or a living related donor kidney first followed by cadaver pancreas transplant? Transplant Proc 25: 1184– 1185, 1993. 57 Sutherland DER, Goetz FC, and Najarian JS: Pancreas transplants from related donors. Transplantation 38: 625– 633, 1984. 58 Sutherland DER, Gruessner RWG, Dunn DL, Moudry-Munns KC, Gruessner AC, and Najarian JS: Pancreas transplants from living related donors. Transplant Proc 26 (6): 443– 445, 1994. 59 Sutherland DER, Gruessner RWG, Moudry-Munns KC, Gruessner AC, Zehrer CL, Gross CR, and Najarian JS: Pancreas transplants alone in nonuremic patients with labile diabetes. Transplant Proc 26: 446– 447, 1994. 60 Kendall DM, Sutherland DER, Goetz FC, and Najarian JS: Metabolic effects of hemipancreatectomy in donors: preoperative prediction of postoperative oral glucose tolerance. Diabetes 38 (suppl): 101– 103, 1989. 61 Kendall DM, Sutherland DER, Najarian JS, Goetz FC, and Robertson RP: Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med 322: 898– 903, 1990. 62 Williams SL, Oler J, and Jorkasky DK: Longterm renal function in kidney donors: a comparison of donors and their siblings. Ann Intern Med 106: 1– 8, 1986. 63 Seaquist ER, and Robertson RP: Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors. J Clin Invest 89: 1761– 1766, 1992. 64 Tydén G, Tibell A, Bolinder J, Ostman J, and Groth CG: Pancreatic transplantation with enteric exocrine diversion: experience with 120 cases. Transplant Proc 24: 771– 773, 1992. 65 Tibell A, Brattström C, Wadstróm J, Tydén G, and Groth CG: Improved results using whole organ pancreatico-duodenal transplants with enteric exocrine drainage. Transplant Proc 26: 412– 413, 1994. 66 Martin X, Lefrancois N, Dawahra M, Bret M, Brunet M, Desmettre O, Garnier JL, Pouteil-Nobel C, and Dubernard JM: Pancreas transplantation in the uremic patient: a random trial of total pancreas with bladder drainage versus duct obstruction of segmental grafts. Transplant Proc 25: 1182– 1183, 1993. 67 Gliedman ML, Gold M, Whittaker J, Rifkin H, Soberman R, Freed S, Tellis VA, and Veith FJ: Clinical segmental pancreatic transplantation with ureter-pancreatic duct anastomosis for exocrine drainage. Surgery 74: 171– 180, 1973. 68 Sollinger HW, Cook K, and Kamps D: Clinical and experimental experience with pancreatic-ocystostomy for exocrine pancreatic drainage in pancreas transplantation. Transplant Proc 16: 749– 751, 1984. 69 Nghiem DD, and Corry RJ: Technique of simultaneous pancreaticoduodenal transplantation with urinary drainage of pancreatic secretion. Am J Surg 153: 405– 400, 1987. 70 Pescovitz MD, Dunn DL, and Sutherland DER: Use of the circular stapler in construction of the duodenoneocystostomy for drainage into the bladder in transplants involving the whole pancreas. Surg Gynecol Obstet 169: 169– 171, 1989. 71 Sollinger HW, Messing EM, Eckhoff DE, Pirsch JD, D'Alessandro AM, Kalayoglu MM, Knechtle SJ, Hickey D, and Belzer FO: Urological complications in 210 consecutive simultaneous pancreas-kidney transplants with bladder drainage. Ann Surg 218: 561– 570, 1993. 72 Burke GW, Gruessner RWG, Dunn DL, and Sutherland DER: Conversion of whole pancreaticoduodenal transplants from bladder to enteric drainage for metabolic acidosis or dysuria. Transplant Proc 22: 651– 652, 1990. 73 Sollinger HW, Sasaki TM, D'Alessandro AM, Knechtle SJ, Pirsch JD, Kalayoglu MM, and Belzer FO: Indications for enteric conversion after pancreas transplantation with bladder drainage. Surgery 112: 842– 846, 1992. 74 Stephanian E, Gruessner RWG, Brayman KL, Gores PF, Dunn DL, Najarian JS, and Sutherland DER: Conversion of exocrine secretions from bladder to enteric drainage in recipients of whole pancreaticoduodenal transplants. Ann Surg 216 (No.6): 663– 672, 1993. 75 Gruessner RWG, Stephanian E, Dunn DL, Gruessner AC, Najarian JS, and Sutherland DER: Cystoenteric conversion after whole pancreaticoduodenal transplantation: indications, risk factors, and outcome. Transplant Proc 25: 1179– 1181, 1993. 76 Martin X, Jemni N, Lefrancois N, Laville M, Tajra LC, Molina G, Dawahra M, and Dubernard JM: Conversion of total bladder-drained pancreas into total injected grafts. Transplant Proc 26: 460, 1994. 77 Gruessner RWG, and Sutherland DER: Clinical diagnosis of pancreas allograft rejection. In Pathology and Rejection Diagnosis in Solid Organ Transplantation, K Solez, LC Racusen, and M Billingham, Eds. Marcel Dekker, New York, 1995, in press. 78 Sutherland DER, Moudry KC, and Najarian JS. Pancreas Transplantation. In Organ Transplantation and Replacement, J Cerilli, Ed. Lippincott, Philadelphia, 1987, pp. 535– 574. 79 Marsh CL, Perkins JD, Sutherland DER, Corry RJ, and Sterioff S: Combined hepatic and pancreaticoduodenal procurement for transplantation. Surg Gynecol Obstet 168: 254– 258, 1989. 80 Delmonico FL, Jenkins RL, Auchincloss H Jr. Etienne TJ, Russell PS, Monaco AP, and Cosimi AB: Procurement of a whole pancreas and liver from the same cadaveric donor. Surgery 105: 718– 723, 1989. 81 Dunn DL, Schlumpf RB, Gruessner RWG, Morel P, Mayoral JL, Payne WD, Matas AJ, Sutherland DER, Moudry-Munns KC, and Najarian JS: Maximal use of liver and pancreas from cadaveric organ donors. Transplant Proc 22: 423– 424, 1990. 82 Gores PF, Gillingham KJ, Dunn DL, Moudry-Munns KC, Najarian JS, and Sutherland DER: Donor hyperglycemia as a minor risk factor and immunologic variables as major risk factors for pancreas allograft loss in a multivariate analysis of a single institution's experience. Ann Surg 215: 217– 230, 1992. 83 Shaffer D, Madras PN, Sahyoun AI, Simpson MA, and Monaco AP: Cadaver donor hyperglycemia does not impair long-term pancreas allograft survival or function. Transplant Proc 26 (2): 439– 440, 1994. 84 Gruessner RWG, Troppmann C, Barrow B, Dunn DL, Moudry-Munns KC, Najarian JS, Sutherland DER, and Gruessner AC: Assessment of donor and recipient risk factors on pancreas transplant outcome. Transplant Proc 26 (2): 437– 438, 1994. 85 Gruessner AC, Gruesner RWG, Moudry-Munns KC, Dunn DL, Najarian JS, and Sutherland DER: Influence of multiple factors (age, transplant number, recipient category, donor source) on outcome of pancreas transplantation at one institution. Transplant Proc 25: 1303– 1305,1993. 86 Florack G, Sutherland DER, Heise JW, and Najarian JS: Successful preservation of human pancreas grafts for 28 hours. Transplant Proc 19: 3882– 3885, 1987. 87 Morel P, Moudry-Munns KC, Najarian JS, Gruessner RWG, Dunn DL, and Sutherland DER: Influence of preservation time on outcome and metabolic function of bladder-drained pancreas transplants. Transplantation 49: 294– 303, 1990. 88 Belzer FO: Clinical organ preservation with UW solution. Transplantation 47: 1097– 1098, 1989. 89 Prieto M, Sutherland DER, Fernandez-Cruz L, Heil JE, and Najarian JS: Experimental and clinical experience with urine amylase monitoring for early diagnosis of rejection in pancreas transplantation. Transplantation 43: 71– 79, 1987. 90 Prieto M, Sutherland DER, Goetz FC, Rosenberg ME, and Najarian JS: Pancreas transplant results according to the technique of duct management: bladder versus enteric drainage. Surgery 102: 680– 691, 1987. 91 Sutherland DER, Kendall DM, Moudry KC, Navarro X, Kennedy WR, Ramsay RC, Steffes MW, Mauer SM, Goetz FC, Dunn DL, and Najarian JS: Pancreas transplantation in nonuremic, type I diabetic recipients. Surgery 104: 453– 464, 1988. 92 Gruessner RWG, Dunn DL, Tzardis PJ, Tomadze G, Moudry-Munns KC, Matas AJ, Najarian JS, and Sutherland DER: Simultaneous pancreas and kidney transplants versus single kidney transplants and previous kidney transplants in uremic patients and single pancreas transplants in nonuremic diabetic patients: comparison of rejection, morbidity, and long-term outcome. Transplant Proc 22: 622– 623, 1990. 93 Sollinger HW, Stratta RJ, D'Alessandro AM, Kalayoglu MM, Pirsch JD, and Belzer FO: Experience with simultaneous pancreas–kidney transplantation. Ann Surg 208: 478– 483, 1988. 94 Nakai I, Kaufman DB, Field MJ, Morel P, and Sutherland DER: Differential effects of preexisting uremia and a synchronous kidney graft on pancreas allograft functional survival in rats. Transplantation 54: 17– 25, 1992. 95 Gruessner RWG, Nakhleh RE, Tzardis PJ, Platt J, Schechner R, Gruessner AC, Tomadze G, Najarian JS, and Sutherland DER: Rejection in single versus combined pancreas and kidney transplantation in pigs. Transplantation 56: 1053– 1062, 1993. 96 Barr D, Bronner MP, Marsh CL, Davis CL, Le Q, McVicar JP, Alpers CE, and Perkins JD: Concordance of histologic rejection in human kidney and pancreas transplantation. Transplantation in press. 97 Davis CL, Alpers CE, Bacchi CE, and Marsh CL: Protocol biopsies of kidney-pancreas transplant recipients. J Am Soc Nephrol 3: 855– 850, 1992. 98 Reinholt FP, Tydén G, Bohman SO, Brattström C, and Groth CG: Pancreatic juice cytology in the diagnosis of pancreatic graft rejection. Clin Transplant 2: 127– 133, 1988. 99 Fernstad R, Skoldefors H, Pousette A, Groth CG, Tydén G, Ost L, Lindholm A, and Carlstrom K: A novel assay for pancreatic cellular damage. III. Use of a pancreas-specific protein as a marker of pancreatic graft dysfunction in humans. Pancreas. 4: 44– 52, 1989. 100 Marks WH, Borgstrom A, Sollinger HW, and Marks C: Serum immunoreactive anodal trypsinogen and urinary amylase as biochemical markers for rejection of clinical whole-organ pancreas allografts having exocrine drainage into the urinary bladder. Transplantation 49: 112– 115, 1990. 101 Munn SR, Engen DE, Barr D, Carpenter HA, and Perkins JD: Differential diagnosis of hypoamylasuria in pancreas allograft recipients with urinary exocrine drainage. Transplantation 49: 359– 362, 1990. 102 Sutherland DER, Casanova D, and Sibley RK: Role of pancreas graft biopsies in the diagnosis and treatment of rejection after pancreas transplantation. Transplant Proc 19: 2329– 2331, 1987. 103 Allen RD, Wilson TG, Grierson JM, Greenberg ML, Earl MJ, Nankivel BJ, and Pearl TAC: Percutaneous biopsy of bladder-drained pancreas transplants. Transplantation 51: 1213– 1216, 1991. 104 Perkins JD, Munn SR, Marsh CL, Barr D, Engen DE, and Carpenter HA: Safety and efficacy of cystoscopically directed biopsy in pancreas transplantation. Transplant Proc 22: 665– 660, 1990. 105 Brayman KL, Moss AA, Morel P, Nakhleh RE, Dunn DL, and Sutherland DER: Exocrine dysfunction evaluation of bladder-drained pancreaticoduodenal transplants using a transcystoscopic biopsy technique. Transplant Proc 24: 901– 902, 1992. 106 Gaber AO, Gaber LW, Shokouh-Amiri MH, and Hathaway DK: Percutaneous biopsy of pancreas transplants. Transplantation 54: 548– 550, 1992. 107 Morel P, Brayman KL, Goetz FC, Kendall DM, Moudry-Munns KC, Chau C, Balakumar M, Stevens RB, Dunn DL, and Sutherland DER: Long-term metabolic function of pancreas transplants and influence of rejection episodes. Transplantation 51: 990– 1000, 1991. 108 Sibley RK, and Sutherland DER: Pancreas transplantation: An immunohistologic and histopathologic examination of 100 grafts. Am J Pathol 128: 151– 170, 1987. 109 Carpenter HA, Engen DE, Munn SR, Barr D, Marsh CL, Ludwig J, and Perkins JD: Histologic diagnosis of rejection by using cystoscopically directed needle biopsy specimens from dysfunctional pancreatoduodenal allografts with exocrine drainage into the bladder. Am J Surg Pathol 14: 837– 846, 1990. 110 Nakhleh RE, Gruessner RWG, Swanson PE, Tzardis PJ, Brayman KL, Dunn DL, and Sutherland DER: Pancreas transplant pathology: a morphologic, immunohistochemical, and electron microscopic comparison of allogeneic grafts with rejection, syngeneic grafts, and chronic pancreatitis. Am J Surg Path 15: 246– 256, 1991. 111 Nakhleh RE, and Sutherland DER: Pancreas rejection: the significance of histopathologic findings with implications for the classification of rejection. Am J Surg Pathol 16: 1098– 1107, 1992. 112 Casanova D, Gruessner RWG, Brayman KL, Jesserun J, Dunn DL, Xenos ES, and Sutherland DER: Retrospective analysis of the role of pancreatic biopsy (open and transcystoscopic technique) in the management of solitary pancreas transplants. Transplant Proc 25: 1192– 1193, 1993. 113 Nakhleh RE, Gruessner RWG, Tzardis PJ, Dunn DL, and Sutherland DER: Pathology of transplanted human duodenal tissue: A histological study, with comparison to pancreatic pathology in resected pancreaticoduodenal transplants. Clin Transplant 5: 241– 247, 1991. 114 Nakhleh RE, Sutherland DER, Benedetti E, Goswitz JJ, and Gruessner RWG: Diagnostic utility and correlation of duodenal and pancreas biopsy tissues in human pancreaticoduodenal transplants with emphasis on therapeutic transplantation. Transplant Proc 27 (1): 1327– 1328, 1995. 115 Benedetti E, Najarian JS, Gruessner AC, Nakhleh RE, Troppmann C, Hakim NS, Pirenne J, and Gruessner RWG: Correlation between cystoscopic biopsy results and hypoamylasuria in bladder-drained pancreas transplants. Transplantation in press. 116 Nakhleh RE, Sutherland DER, Tzardis PJ, Schechner R, and Gruessner RWG: Correlation of rejection of the duodenum with rejection of the pancreas in a pig model of pancreaticoduodenal transplantation. Transplantation 56: 1353– 1356, 1993. 117 Sutherland DER, Gruessner RWG, Moudry-Munns KC, and Gruessner AC: Discordant graft loss from rejection of organs from the same donor in simultaneous pancreas-kidney recipients. Transplant Proc 27 (1): 907– 908, 1995. 118 Barrou B, Barrou Z, Gruessner AC, Moudry-Munns KC, Gruessner RWG, and Sutherland DER: Probability of retaining endocrine function (insulin-indepen- dence) after definitive loss of exocrine function in bladder-drained pancreas transplants. Transplant Proc 26 (2): 473– 474, 1994. 119 Sutherland DER, Moudry-Munns KC, and Gruessner AC: Pancreas transplant outcome with or without biological anti-T-cell therapy for induction immunosuppression with use of cyclosporine. Transplant Proc 26 (5): 2752– 2755, 1994. 120 Gruessner RWG, Sutherland DER, Drangstveit MB, Troppman C and Gruessner AC. Use of FK506 in pancreas transplantation. Clin Transplant in press. 121 Sutherland DER, Gruessner RWG, Gillingham KJ, Moudry Munns KC, Dunn DL, Brayman KL, Morel Pand Najarian JS A single institution's experience with solitary pancreas transplantation. In Clinical Transplants–1991, PI Terasaki, Ed. UCLA Tissue Typing Laboratory, Los Angeles, 1992, pp. 141– 152. 122 Tesi RJ, Henry ML, Elkhammas EA, Davies EA, and Ferguson RM: The frequency of rejection episodes after combined kidney–pancreas transplant-the impact on graft survival. Transplantation 58: 424– 430, 1994. 123 Sutherland DER: Pancreas transplants in nonuremic and post-uremic diabetic patients. Transplant Proc 24: 780– 781, 1992. 124 Stratta RJ, Taylor RJ, Bynon JS, Lowell JA, Sindhi R, Wahl TO, Knight TF, Weide LG, and Duckworth WC: Surgical treatment of diabetes mellitus wi
Publication Year: 1995
Publication Date: 1995-12-01
Language: en
Type: review
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 38
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot